OCS starts PIONEER-1 trial after first Privosegtor patient treated
OCS says it has treated the first patient in its PIONEER-1 registrational trial of Privosegtor for optic neuritis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.